Australia / Australian Capital Territory territory guide

Peptides in Australian Capital Territory: check the ARTG and local supply record.

A Australian Capital Territory-specific peptide guide connecting national TGA product records and practitioner registration to ACT Government's official territory route for pharmacy, premises, or medicines-supply claims.

Market brief

What changes in Australian Capital Territory.

In Australian Capital Territory, an Australian domain, local address, clinic page, pharmacy name, or delivery promise does not establish that a peptide product is included in the ARTG or that its supply route is supported. ACT Government provides the territory regulator for community pharmacy ownership, premises, medicines, poisons, and therapeutic goods.

  • ACT Government provides the territory regulator for community pharmacy ownership, premises, medicines, poisons, and therapeutic goods; use the current official route instead of a badge, screenshot, local phone number, or seller-supplied credential alone.
  • The TGA states that a research-use disclaimer does not by itself make import, manufacture, advertising, compounding, or supply of an unapproved peptide product lawful.
  • Peptide Local does not publish a Australian Capital Territory seller ranking until product category, national record, local authority route, Australian delivery, exact price, and observation date are sourced together.
Verification route

Know which record answers which question.

Local checklist

Three checks before any comparison.

Use this checklist to verify the local product, seller, and supply records before comparing price or availability.

01

Resolve the territory record

Open pharmaceutical services and match the legal business, premises, licence, registration, or supply category behind an offer involving Australian Capital Territory.

02

Check the exact product nationally

Search the ARTG for the product, sponsor, active ingredient, dosage form, and identifier. If no record resolves, identify the exact exemption or access pathway instead of treating a shared name as authorization.

03

Keep the supply category attached

Separate prescription medicines, pharmacy services, compounded preparations, personal imports, clinical programs, and research-labelled materials before comparing any price or availability claim.

Direct answers

What this guide can - and cannot - answer.

Each answer is tied to the local records below so you can see what is confirmed, what remains unknown, and where to recheck it. Open the primary sources ↓

01

Can every peptide offer be treated as legal to buy in Australian Capital Territory?

No blanket answer is supportable. Open pharmaceutical services and match the legal business, premises, licence, registration, or supply category behind an offer involving Australian Capital Territory. In Australian Capital Territory, begin with Pharmaceutical Services from ACT Government; the product, seller, and supply route still need to resolve to the same current record.

02

Does this page name the best place to buy peptides in Australian Capital Territory?

No. Peptide Local withholds a commercial table for Australian Capital Territory until seller category, local delivery, regulatory or research status, exact price, and observation date are all sourced. This page is a verification route, not a shopping recommendation.

03

Which official records should I check first in Australian Capital Territory?

For Australian Capital Territory, start with Pharmaceutical Services from ACT Government, then open Searching the Australian Register of Therapeutic Goods from Therapeutic Goods Administration. The records answer separate questions, so confirm each current entry instead of treating one match as proof of the seller, product, and route together.

Compound and jurisdiction routes

Tracked peptide names in Australian Capital Territory.

Each answer preserves the compound’s research, clinical, or medicine identity, connects it to the ARTG and practitioner register when relevant, and then points to the official Australian Capital Territory route. A shared name or local record is not a blanket product, seller, legal, or availability finding.

01FDA-reviewed unapproved peptide identity

KPV in Australian Capital Territory

KPV in Australian Capital Territory begins with a research-market identity, not a finding that a same-name product is included in the ARTG, lawfully supplied, locally available, independently tested, or appropriate for use in Australia. A research-use disclaimer cannot resolve those questions by itself. For a pharmacy, clinic, practitioner, importer, or seller claim involving Australian Capital Territory, open Pharmaceutical Services from ACT Government and match the business, premises, licence, registration, supply category, and current status. Then search the exact product and sponsor separately in the Australian Register of Therapeutic Goods and check the practitioner in Ahpra when relevant. A local record does not authorize a product, and an ARTG record does not validate a different seller, parcel, or service.

Official jurisdiction routePharmaceutical ServicesACT Government
02US research-market identity

BPC-157 in Australian Capital Territory

BPC-157 in Australian Capital Territory begins with a research-market identity, not a finding that a same-name product is included in the ARTG, lawfully supplied, locally available, independently tested, or appropriate for use in Australia. A research-use disclaimer cannot resolve those questions by itself. For a pharmacy, clinic, practitioner, importer, or seller claim involving Australian Capital Territory, open Pharmaceutical Services from ACT Government and match the business, premises, licence, registration, supply category, and current status. Then search the exact product and sponsor separately in the Australian Register of Therapeutic Goods and check the practitioner in Ahpra when relevant. A local record does not authorize a product, and an ARTG record does not validate a different seller, parcel, or service.

Official jurisdiction routePharmaceutical ServicesACT Government
03US research-market identity

TB-500 in Australian Capital Territory

TB-500 in Australian Capital Territory begins with a research-market identity, not a finding that a same-name product is included in the ARTG, lawfully supplied, locally available, independently tested, or appropriate for use in Australia. A research-use disclaimer cannot resolve those questions by itself. For a pharmacy, clinic, practitioner, importer, or seller claim involving Australian Capital Territory, open Pharmaceutical Services from ACT Government and match the business, premises, licence, registration, supply category, and current status. Then search the exact product and sponsor separately in the Australian Register of Therapeutic Goods and check the practitioner in Ahpra when relevant. A local record does not authorize a product, and an ARTG record does not validate a different seller, parcel, or service.

Official jurisdiction routePharmaceutical ServicesACT Government
04US research-market identity

GHK-Cu in Australian Capital Territory

GHK-Cu in Australian Capital Territory begins with a research-market identity, not a finding that a same-name product is included in the ARTG, lawfully supplied, locally available, independently tested, or appropriate for use in Australia. A research-use disclaimer cannot resolve those questions by itself. For a pharmacy, clinic, practitioner, importer, or seller claim involving Australian Capital Territory, open Pharmaceutical Services from ACT Government and match the business, premises, licence, registration, supply category, and current status. Then search the exact product and sponsor separately in the Australian Register of Therapeutic Goods and check the practitioner in Ahpra when relevant. A local record does not authorize a product, and an ARTG record does not validate a different seller, parcel, or service.

Official jurisdiction routePharmaceutical ServicesACT Government
05US research-market identity

Semax in Australian Capital Territory

Semax in Australian Capital Territory begins with a research-market identity, not a finding that a same-name product is included in the ARTG, lawfully supplied, locally available, independently tested, or appropriate for use in Australia. A research-use disclaimer cannot resolve those questions by itself. For a pharmacy, clinic, practitioner, importer, or seller claim involving Australian Capital Territory, open Pharmaceutical Services from ACT Government and match the business, premises, licence, registration, supply category, and current status. Then search the exact product and sponsor separately in the Australian Register of Therapeutic Goods and check the practitioner in Ahpra when relevant. A local record does not authorize a product, and an ARTG record does not validate a different seller, parcel, or service.

Official jurisdiction routePharmaceutical ServicesACT Government
06US research-market identity

Melanotan II in Australian Capital Territory

Melanotan II in Australian Capital Territory begins with a research-market identity, not a finding that a same-name product is included in the ARTG, lawfully supplied, locally available, independently tested, or appropriate for use in Australia. A research-use disclaimer cannot resolve those questions by itself. For a pharmacy, clinic, practitioner, importer, or seller claim involving Australian Capital Territory, open Pharmaceutical Services from ACT Government and match the business, premises, licence, registration, supply category, and current status. Then search the exact product and sponsor separately in the Australian Register of Therapeutic Goods and check the practitioner in Ahpra when relevant. A local record does not authorize a product, and an ARTG record does not validate a different seller, parcel, or service.

Official jurisdiction routePharmaceutical ServicesACT Government
07US research-market identity

MOTS-c in Australian Capital Territory

MOTS-c in Australian Capital Territory begins with a research-market identity, not a finding that a same-name product is included in the ARTG, lawfully supplied, locally available, independently tested, or appropriate for use in Australia. A research-use disclaimer cannot resolve those questions by itself. For a pharmacy, clinic, practitioner, importer, or seller claim involving Australian Capital Territory, open Pharmaceutical Services from ACT Government and match the business, premises, licence, registration, supply category, and current status. Then search the exact product and sponsor separately in the Australian Register of Therapeutic Goods and check the practitioner in Ahpra when relevant. A local record does not authorize a product, and an ARTG record does not validate a different seller, parcel, or service.

Official jurisdiction routePharmaceutical ServicesACT Government
08US research-market identity with a separate FDA-licensed medicine record

Tesamorelin in Australian Capital Territory

Tesamorelin in Australian Capital Territory begins with a research-market identity, not a finding that a same-name product is included in the ARTG, lawfully supplied, locally available, independently tested, or appropriate for use in Australia. A research-use disclaimer cannot resolve those questions by itself. For a pharmacy, clinic, practitioner, importer, or seller claim involving Australian Capital Territory, open Pharmaceutical Services from ACT Government and match the business, premises, licence, registration, supply category, and current status. Then search the exact product and sponsor separately in the Australian Register of Therapeutic Goods and check the practitioner in Ahpra when relevant. A local record does not authorize a product, and an ARTG record does not validate a different seller, parcel, or service.

Official jurisdiction routePharmaceutical ServicesACT Government
09US research-market identity with a failed oral obesity program and no FDA-approved drug

AOD-9604 in Australian Capital Territory

AOD-9604 in Australian Capital Territory begins with a research-market identity, not a finding that a same-name product is included in the ARTG, lawfully supplied, locally available, independently tested, or appropriate for use in Australia. A research-use disclaimer cannot resolve those questions by itself. For a pharmacy, clinic, practitioner, importer, or seller claim involving Australian Capital Territory, open Pharmaceutical Services from ACT Government and match the business, premises, licence, registration, supply category, and current status. Then search the exact product and sponsor separately in the Australian Register of Therapeutic Goods and check the practitioner in Ahpra when relevant. A local record does not authorize a product, and an ARTG record does not validate a different seller, parcel, or service.

Official jurisdiction routePharmaceutical ServicesACT Government
10US research-market identity

Ipamorelin in Australian Capital Territory

Ipamorelin in Australian Capital Territory begins with a research-market identity, not a finding that a same-name product is included in the ARTG, lawfully supplied, locally available, independently tested, or appropriate for use in Australia. A research-use disclaimer cannot resolve those questions by itself. For a pharmacy, clinic, practitioner, importer, or seller claim involving Australian Capital Territory, open Pharmaceutical Services from ACT Government and match the business, premises, licence, registration, supply category, and current status. Then search the exact product and sponsor separately in the Australian Register of Therapeutic Goods and check the practitioner in Ahpra when relevant. A local record does not authorize a product, and an ARTG record does not validate a different seller, parcel, or service.

Official jurisdiction routePharmaceutical ServicesACT Government
11US research-market identity

Selank in Australian Capital Territory

Selank in Australian Capital Territory begins with a research-market identity, not a finding that a same-name product is included in the ARTG, lawfully supplied, locally available, independently tested, or appropriate for use in Australia. A research-use disclaimer cannot resolve those questions by itself. For a pharmacy, clinic, practitioner, importer, or seller claim involving Australian Capital Territory, open Pharmaceutical Services from ACT Government and match the business, premises, licence, registration, supply category, and current status. Then search the exact product and sponsor separately in the Australian Register of Therapeutic Goods and check the practitioner in Ahpra when relevant. A local record does not authorize a product, and an ARTG record does not validate a different seller, parcel, or service.

Official jurisdiction routePharmaceutical ServicesACT Government
12US research-market identity with a separate FDA-approved medicine record

PT-141 / Bremelanotide in Australian Capital Territory

PT-141 / Bremelanotide in Australian Capital Territory begins with a research-market identity, not a finding that a same-name product is included in the ARTG, lawfully supplied, locally available, independently tested, or appropriate for use in Australia. A research-use disclaimer cannot resolve those questions by itself. For a pharmacy, clinic, practitioner, importer, or seller claim involving Australian Capital Territory, open Pharmaceutical Services from ACT Government and match the business, premises, licence, registration, supply category, and current status. Then search the exact product and sponsor separately in the Australian Register of Therapeutic Goods and check the practitioner in Ahpra when relevant. A local record does not authorize a product, and an ARTG record does not validate a different seller, parcel, or service.

Official jurisdiction routePharmaceutical ServicesACT Government
13US research-market identity

CJC-1295 no DAC in Australian Capital Territory

CJC-1295 no DAC in Australian Capital Territory begins with a research-market identity, not a finding that a same-name product is included in the ARTG, lawfully supplied, locally available, independently tested, or appropriate for use in Australia. A research-use disclaimer cannot resolve those questions by itself. For a pharmacy, clinic, practitioner, importer, or seller claim involving Australian Capital Territory, open Pharmaceutical Services from ACT Government and match the business, premises, licence, registration, supply category, and current status. Then search the exact product and sponsor separately in the Australian Register of Therapeutic Goods and check the practitioner in Ahpra when relevant. A local record does not authorize a product, and an ARTG record does not validate a different seller, parcel, or service.

Official jurisdiction routePharmaceutical ServicesACT Government
14US research-market identity

CJC-1295 DAC in Australian Capital Territory

CJC-1295 DAC in Australian Capital Territory begins with a research-market identity, not a finding that a same-name product is included in the ARTG, lawfully supplied, locally available, independently tested, or appropriate for use in Australia. A research-use disclaimer cannot resolve those questions by itself. For a pharmacy, clinic, practitioner, importer, or seller claim involving Australian Capital Territory, open Pharmaceutical Services from ACT Government and match the business, premises, licence, registration, supply category, and current status. Then search the exact product and sponsor separately in the Australian Register of Therapeutic Goods and check the practitioner in Ahpra when relevant. A local record does not authorize a product, and an ARTG record does not validate a different seller, parcel, or service.

Official jurisdiction routePharmaceutical ServicesACT Government
15Investigational clinical program

Retatrutide in Australian Capital Territory

Retatrutide in Australian Capital Territory refers first to an investigational clinical program, not an approved Australian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, manufacturing controls, or regulatory status. For a pharmacy, clinic, practitioner, importer, or seller claim involving Australian Capital Territory, open Pharmaceutical Services from ACT Government and match the business, premises, licence, registration, supply category, and current status. Then search the exact product and sponsor separately in the Australian Register of Therapeutic Goods and check the practitioner in Ahpra when relevant. A local record does not authorize a product, and an ARTG record does not validate a different seller, parcel, or service.

Official jurisdiction routePharmaceutical ServicesACT Government
16China-approved medicine and active clinical program

Mazdutide in Australian Capital Territory

Mazdutide in Australian Capital Territory refers first to an investigational clinical program, not an approved Australian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, manufacturing controls, or regulatory status. For a pharmacy, clinic, practitioner, importer, or seller claim involving Australian Capital Territory, open Pharmaceutical Services from ACT Government and match the business, premises, licence, registration, supply category, and current status. Then search the exact product and sponsor separately in the Australian Register of Therapeutic Goods and check the practitioner in Ahpra when relevant. A local record does not authorize a product, and an ARTG record does not validate a different seller, parcel, or service.

Official jurisdiction routePharmaceutical ServicesACT Government
17China-approved medicine and active development program

Ecnoglutide in Australian Capital Territory

Ecnoglutide in Australian Capital Territory refers first to an investigational clinical program, not an approved Australian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, manufacturing controls, or regulatory status. For a pharmacy, clinic, practitioner, importer, or seller claim involving Australian Capital Territory, open Pharmaceutical Services from ACT Government and match the business, premises, licence, registration, supply category, and current status. Then search the exact product and sponsor separately in the Australian Register of Therapeutic Goods and check the practitioner in Ahpra when relevant. A local record does not authorize a product, and an ARTG record does not validate a different seller, parcel, or service.

Official jurisdiction routePharmaceutical ServicesACT Government
18Investigational clinical program

Enicepatide in Australian Capital Territory

Enicepatide in Australian Capital Territory refers first to an investigational clinical program, not an approved Australian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, manufacturing controls, or regulatory status. For a pharmacy, clinic, practitioner, importer, or seller claim involving Australian Capital Territory, open Pharmaceutical Services from ACT Government and match the business, premises, licence, registration, supply category, and current status. Then search the exact product and sponsor separately in the Australian Register of Therapeutic Goods and check the practitioner in Ahpra when relevant. A local record does not authorize a product, and an ARTG record does not validate a different seller, parcel, or service.

Official jurisdiction routePharmaceutical ServicesACT Government
19Investigational clinical program

Eloralintide in Australian Capital Territory

Eloralintide in Australian Capital Territory refers first to an investigational clinical program, not an approved Australian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, manufacturing controls, or regulatory status. For a pharmacy, clinic, practitioner, importer, or seller claim involving Australian Capital Territory, open Pharmaceutical Services from ACT Government and match the business, premises, licence, registration, supply category, and current status. Then search the exact product and sponsor separately in the Australian Register of Therapeutic Goods and check the practitioner in Ahpra when relevant. A local record does not authorize a product, and an ARTG record does not validate a different seller, parcel, or service.

Official jurisdiction routePharmaceutical ServicesACT Government
20Investigational clinical program

Cagrilintide in Australian Capital Territory

Cagrilintide in Australian Capital Territory refers first to an investigational clinical program, not an approved Australian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, manufacturing controls, or regulatory status. For a pharmacy, clinic, practitioner, importer, or seller claim involving Australian Capital Territory, open Pharmaceutical Services from ACT Government and match the business, premises, licence, registration, supply category, and current status. Then search the exact product and sponsor separately in the Australian Register of Therapeutic Goods and check the practitioner in Ahpra when relevant. A local record does not authorize a product, and an ARTG record does not validate a different seller, parcel, or service.

Official jurisdiction routePharmaceutical ServicesACT Government
21Investigational clinical program

Petrelintide in Australian Capital Territory

Petrelintide in Australian Capital Territory refers first to an investigational clinical program, not an approved Australian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, manufacturing controls, or regulatory status. For a pharmacy, clinic, practitioner, importer, or seller claim involving Australian Capital Territory, open Pharmaceutical Services from ACT Government and match the business, premises, licence, registration, supply category, and current status. Then search the exact product and sponsor separately in the Australian Register of Therapeutic Goods and check the practitioner in Ahpra when relevant. A local record does not authorize a product, and an ARTG record does not validate a different seller, parcel, or service.

Official jurisdiction routePharmaceutical ServicesACT Government
22Investigational clinical program

CagriSema in Australian Capital Territory

CagriSema in Australian Capital Territory refers first to an investigational clinical program, not an approved Australian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, manufacturing controls, or regulatory status. For a pharmacy, clinic, practitioner, importer, or seller claim involving Australian Capital Territory, open Pharmaceutical Services from ACT Government and match the business, premises, licence, registration, supply category, and current status. Then search the exact product and sponsor separately in the Australian Register of Therapeutic Goods and check the practitioner in Ahpra when relevant. A local record does not authorize a product, and an ARTG record does not validate a different seller, parcel, or service.

Official jurisdiction routePharmaceutical ServicesACT Government
23Investigational clinical program

MariTide in Australian Capital Territory

MariTide in Australian Capital Territory refers first to an investigational clinical program, not an approved Australian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, manufacturing controls, or regulatory status. For a pharmacy, clinic, practitioner, importer, or seller claim involving Australian Capital Territory, open Pharmaceutical Services from ACT Government and match the business, premises, licence, registration, supply category, and current status. Then search the exact product and sponsor separately in the Australian Register of Therapeutic Goods and check the practitioner in Ahpra when relevant. A local record does not authorize a product, and an ARTG record does not validate a different seller, parcel, or service.

Official jurisdiction routePharmaceutical ServicesACT Government
24Investigational clinical program

Survodutide in Australian Capital Territory

Survodutide in Australian Capital Territory refers first to an investigational clinical program, not an approved Australian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, manufacturing controls, or regulatory status. For a pharmacy, clinic, practitioner, importer, or seller claim involving Australian Capital Territory, open Pharmaceutical Services from ACT Government and match the business, premises, licence, registration, supply category, and current status. Then search the exact product and sponsor separately in the Australian Register of Therapeutic Goods and check the practitioner in Ahpra when relevant. A local record does not authorize a product, and an ARTG record does not validate a different seller, parcel, or service.

Official jurisdiction routePharmaceutical ServicesACT Government
25Investigational clinical program

VK2735 in Australian Capital Territory

VK2735 in Australian Capital Territory refers first to an investigational clinical program, not an approved Australian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, manufacturing controls, or regulatory status. For a pharmacy, clinic, practitioner, importer, or seller claim involving Australian Capital Territory, open Pharmaceutical Services from ACT Government and match the business, premises, licence, registration, supply category, and current status. Then search the exact product and sponsor separately in the Australian Register of Therapeutic Goods and check the practitioner in Ahpra when relevant. A local record does not authorize a product, and an ARTG record does not validate a different seller, parcel, or service.

Official jurisdiction routePharmaceutical ServicesACT Government
26Investigational clinical program

Pemvidutide in Australian Capital Territory

Pemvidutide in Australian Capital Territory refers first to an investigational clinical program, not an approved Australian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, manufacturing controls, or regulatory status. For a pharmacy, clinic, practitioner, importer, or seller claim involving Australian Capital Territory, open Pharmaceutical Services from ACT Government and match the business, premises, licence, registration, supply category, and current status. Then search the exact product and sponsor separately in the Australian Register of Therapeutic Goods and check the practitioner in Ahpra when relevant. A local record does not authorize a product, and an ARTG record does not validate a different seller, parcel, or service.

Official jurisdiction routePharmaceutical ServicesACT Government
27Investigational clinical program

Amycretin / Zenagamtide in Australian Capital Territory

Amycretin / Zenagamtide in Australian Capital Territory refers first to an investigational clinical program, not an approved Australian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, manufacturing controls, or regulatory status. For a pharmacy, clinic, practitioner, importer, or seller claim involving Australian Capital Territory, open Pharmaceutical Services from ACT Government and match the business, premises, licence, registration, supply category, and current status. Then search the exact product and sponsor separately in the Australian Register of Therapeutic Goods and check the practitioner in Ahpra when relevant. A local record does not authorize a product, and an ARTG record does not validate a different seller, parcel, or service.

Official jurisdiction routePharmaceutical ServicesACT Government
28US FDA medicine reference

Tirzepatide in Australian Capital Territory

Tirzepatide in Australian Capital Territory begins with a medicine identity, but Australian authorization belongs to an exact therapeutic good, sponsor, presentation, route, ARTG record, and regulated supply path. A shared ingredient or brand reference does not transfer that record to every listing. For a pharmacy, clinic, practitioner, importer, or seller claim involving Australian Capital Territory, open Pharmaceutical Services from ACT Government and match the business, premises, licence, registration, supply category, and current status. Then search the exact product and sponsor separately in the Australian Register of Therapeutic Goods and check the practitioner in Ahpra when relevant. A local record does not authorize a product, and an ARTG record does not validate a different seller, parcel, or service.

Official jurisdiction routePharmaceutical ServicesACT Government
29FDA-approved US medicine with country-specific status elsewhere

Orforglipron / Foundayo in Australian Capital Territory

Orforglipron / Foundayo in Australian Capital Territory begins with a medicine identity, but Australian authorization belongs to an exact therapeutic good, sponsor, presentation, route, ARTG record, and regulated supply path. A shared ingredient or brand reference does not transfer that record to every listing. For a pharmacy, clinic, practitioner, importer, or seller claim involving Australian Capital Territory, open Pharmaceutical Services from ACT Government and match the business, premises, licence, registration, supply category, and current status. Then search the exact product and sponsor separately in the Australian Register of Therapeutic Goods and check the practitioner in Ahpra when relevant. A local record does not authorize a product, and an ARTG record does not validate a different seller, parcel, or service.

Official jurisdiction routePharmaceutical ServicesACT Government
30Product-specific approved medicine records in multiple jurisdictions

Semaglutide in Australian Capital Territory

Semaglutide in Australian Capital Territory begins with a medicine identity, but Australian authorization belongs to an exact therapeutic good, sponsor, presentation, route, ARTG record, and regulated supply path. A shared ingredient or brand reference does not transfer that record to every listing. For a pharmacy, clinic, practitioner, importer, or seller claim involving Australian Capital Territory, open Pharmaceutical Services from ACT Government and match the business, premises, licence, registration, supply category, and current status. Then search the exact product and sponsor separately in the Australian Register of Therapeutic Goods and check the practitioner in Ahpra when relevant. A local record does not authorize a product, and an ARTG record does not validate a different seller, parcel, or service.

Official jurisdiction routePharmaceutical ServicesACT Government
31FDA-flagged unapproved research-market peptide identity

DSIP / Emideltide in Australian Capital Territory

DSIP / Emideltide in Australian Capital Territory begins with a research-market identity, not a finding that a same-name product is included in the ARTG, lawfully supplied, locally available, independently tested, or appropriate for use in Australia. A research-use disclaimer cannot resolve those questions by itself. For a pharmacy, clinic, practitioner, importer, or seller claim involving Australian Capital Territory, open Pharmaceutical Services from ACT Government and match the business, premises, licence, registration, supply category, and current status. Then search the exact product and sponsor separately in the Australian Register of Therapeutic Goods and check the practitioner in Ahpra when relevant. A local record does not authorize a product, and an ARTG record does not validate a different seller, parcel, or service.

Official jurisdiction routePharmaceutical ServicesACT Government
32US research-market identity

IGF-1 LR3 in Australian Capital Territory

IGF-1 LR3 in Australian Capital Territory begins with a research-market identity, not a finding that a same-name product is included in the ARTG, lawfully supplied, locally available, independently tested, or appropriate for use in Australia. A research-use disclaimer cannot resolve those questions by itself. For a pharmacy, clinic, practitioner, importer, or seller claim involving Australian Capital Territory, open Pharmaceutical Services from ACT Government and match the business, premises, licence, registration, supply category, and current status. Then search the exact product and sponsor separately in the Australian Register of Therapeutic Goods and check the practitioner in Ahpra when relevant. A local record does not authorize a product, and an ARTG record does not validate a different seller, parcel, or service.

Official jurisdiction routePharmaceutical ServicesACT Government
33US research-market identity

Kisspeptin-10 / KP-10 in Australian Capital Territory

Kisspeptin-10 / KP-10 in Australian Capital Territory begins with a research-market identity, not a finding that a same-name product is included in the ARTG, lawfully supplied, locally available, independently tested, or appropriate for use in Australia. A research-use disclaimer cannot resolve those questions by itself. For a pharmacy, clinic, practitioner, importer, or seller claim involving Australian Capital Territory, open Pharmaceutical Services from ACT Government and match the business, premises, licence, registration, supply category, and current status. Then search the exact product and sponsor separately in the Australian Register of Therapeutic Goods and check the practitioner in Ahpra when relevant. A local record does not authorize a product, and an ARTG record does not validate a different seller, parcel, or service.

Official jurisdiction routePharmaceutical ServicesACT Government
34US research-market identity separated from SCENESSE

Melanotan I in Australian Capital Territory

Melanotan I in Australian Capital Territory begins with a research-market identity, not a finding that a same-name product is included in the ARTG, lawfully supplied, locally available, independently tested, or appropriate for use in Australia. A research-use disclaimer cannot resolve those questions by itself. For a pharmacy, clinic, practitioner, importer, or seller claim involving Australian Capital Territory, open Pharmaceutical Services from ACT Government and match the business, premises, licence, registration, supply category, and current status. Then search the exact product and sponsor separately in the Australian Register of Therapeutic Goods and check the practitioner in Ahpra when relevant. A local record does not authorize a product, and an ARTG record does not validate a different seller, parcel, or service.

Official jurisdiction routePharmaceutical ServicesACT Government
35US research-market non-peptide coenzyme identity

NAD+ in Australian Capital Territory

NAD+ in Australian Capital Territory begins with a research-market identity, not a finding that a same-name product is included in the ARTG, lawfully supplied, locally available, independently tested, or appropriate for use in Australia. A research-use disclaimer cannot resolve those questions by itself. For a pharmacy, clinic, practitioner, importer, or seller claim involving Australian Capital Territory, open Pharmaceutical Services from ACT Government and match the business, premises, licence, registration, supply category, and current status. Then search the exact product and sponsor separately in the Australian Register of Therapeutic Goods and check the practitioner in Ahpra when relevant. A local record does not authorize a product, and an ARTG record does not validate a different seller, parcel, or service.

Official jurisdiction routePharmaceutical ServicesACT Government
36US research-market identity with a withdrawn historical medicine record

Sermorelin in Australian Capital Territory

Sermorelin in Australian Capital Territory begins with a research-market identity, not a finding that a same-name product is included in the ARTG, lawfully supplied, locally available, independently tested, or appropriate for use in Australia. A research-use disclaimer cannot resolve those questions by itself. For a pharmacy, clinic, practitioner, importer, or seller claim involving Australian Capital Territory, open Pharmaceutical Services from ACT Government and match the business, premises, licence, registration, supply category, and current status. Then search the exact product and sponsor separately in the Australian Register of Therapeutic Goods and check the practitioner in Ahpra when relevant. A local record does not authorize a product, and an ARTG record does not validate a different seller, parcel, or service.

Official jurisdiction routePharmaceutical ServicesACT Government
37No FDA-approved US product; exact foreign prescription products exist

Thymosin Alpha-1 in Australian Capital Territory

Thymosin Alpha-1 in Australian Capital Territory begins with a research-market identity, not a finding that a same-name product is included in the ARTG, lawfully supplied, locally available, independently tested, or appropriate for use in Australia. A research-use disclaimer cannot resolve those questions by itself. For a pharmacy, clinic, practitioner, importer, or seller claim involving Australian Capital Territory, open Pharmaceutical Services from ACT Government and match the business, premises, licence, registration, supply category, and current status. Then search the exact product and sponsor separately in the Australian Register of Therapeutic Goods and check the practitioner in Ahpra when relevant. A local record does not authorize a product, and an ARTG record does not validate a different seller, parcel, or service.

Official jurisdiction routePharmaceutical ServicesACT Government
38FDA-approved US medicine with a withdrawn EU application

EGRIFTA WR in Australian Capital Territory

EGRIFTA WR in Australian Capital Territory begins with a medicine identity, but Australian authorization belongs to an exact therapeutic good, sponsor, presentation, route, ARTG record, and regulated supply path. A shared ingredient or brand reference does not transfer that record to every listing. For a pharmacy, clinic, practitioner, importer, or seller claim involving Australian Capital Territory, open Pharmaceutical Services from ACT Government and match the business, premises, licence, registration, supply category, and current status. Then search the exact product and sponsor separately in the Australian Register of Therapeutic Goods and check the practitioner in Ahpra when relevant. A local record does not authorize a product, and an ARTG record does not validate a different seller, parcel, or service.

Official jurisdiction routePharmaceutical ServicesACT Government
39Product-specific FDA and EU medicine records

Liraglutide in Australian Capital Territory

Liraglutide in Australian Capital Territory begins with a medicine identity, but Australian authorization belongs to an exact therapeutic good, sponsor, presentation, route, ARTG record, and regulated supply path. A shared ingredient or brand reference does not transfer that record to every listing. For a pharmacy, clinic, practitioner, importer, or seller claim involving Australian Capital Territory, open Pharmaceutical Services from ACT Government and match the business, premises, licence, registration, supply category, and current status. Then search the exact product and sponsor separately in the Australian Register of Therapeutic Goods and check the practitioner in Ahpra when relevant. A local record does not authorize a product, and an ARTG record does not validate a different seller, parcel, or service.

Official jurisdiction routePharmaceutical ServicesACT Government
40Product-specific FDA and EU medicine records

SCENESSE in Australian Capital Territory

SCENESSE in Australian Capital Territory begins with a medicine identity, but Australian authorization belongs to an exact therapeutic good, sponsor, presentation, route, ARTG record, and regulated supply path. A shared ingredient or brand reference does not transfer that record to every listing. For a pharmacy, clinic, practitioner, importer, or seller claim involving Australian Capital Territory, open Pharmaceutical Services from ACT Government and match the business, premises, licence, registration, supply category, and current status. Then search the exact product and sponsor separately in the Australian Register of Therapeutic Goods and check the practitioner in Ahpra when relevant. A local record does not authorize a product, and an ARTG record does not validate a different seller, parcel, or service.

Official jurisdiction routePharmaceutical ServicesACT Government
41Product-specific FDA-approved US medicine record

VYLEESI in Australian Capital Territory

VYLEESI in Australian Capital Territory begins with a medicine identity, but Australian authorization belongs to an exact therapeutic good, sponsor, presentation, route, ARTG record, and regulated supply path. A shared ingredient or brand reference does not transfer that record to every listing. For a pharmacy, clinic, practitioner, importer, or seller claim involving Australian Capital Territory, open Pharmaceutical Services from ACT Government and match the business, premises, licence, registration, supply category, and current status. Then search the exact product and sponsor separately in the Australian Register of Therapeutic Goods and check the practitioner in Ahpra when relevant. A local record does not authorize a product, and an ARTG record does not validate a different seller, parcel, or service.

Official jurisdiction routePharmaceutical ServicesACT Government
00
Publishing gate

No commercial price table yet.

Peptide Local will not manufacture a ranking from thin data. A local table appears only after seller category, authorization or research status, delivery market, price, and source date can all be stated clearly.

Primary sources

Repeat the checks yourself.

Official sources are linked directly. Open them to confirm the current record; this page is a guide, not a substitute for the regulator.

Related guides